Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
PaperCitations, authors & open-access status
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 194 citations, 2020 year and hybrid oa status.
194
Citations
2020
Year
hybrid
OA Status